CVE-2026-50034
Apollo Pharmacy Blood Glucose Monitoring System APG-01 BT Cleartext Transmission of Sensitive Information
- Published
- Last modified
- Where the record stands: published, rejected by its publisher, or superseded by another id.What do these mean? →
- published
- Whether CISA lists it in its Known Exploited Vulnerabilities catalog: proof that attackers are using it.What do these mean? →
- Not listed in CISA KEV
- Whether working attack code is public (Exploit-DB, Metasploit, Nuclei or GitHub). Public code makes attacks easier.What do these mean? →
- None on Exploit-DB, Metasploit or GitHub
CISA's decision points: whether it is exploited, whether attacks can be automated, and how much control an attacker gets. Assessed (SSVC 2.0.3).What do these mean? →
- Exploitation: none
- Automatable: no
- Technical impact: partial
Summary
An attacker within BLE communication range can passively intercept wireless traffic and obtain sensitive health-related information, including glucose measurement values.
Timeline
- CVE published
- CISA SSVC assessment
Exploitation: none · Automatable: no · Technical impact: partial
- Record last updated
Affected versions
- Apollo Pharmacy Blood Glucose Monitoring System (Model No. APG-01 BT)
0x0110_v1.1.0